ACTAVIA LIFE SCIENCES, INC. Pre-Tax Income
ACTAVIA LIFE SCIENCES, INC. reported Pre-Tax Income of -$332 for the 12-month period ending 2021-09-30, per its 10-K filed 2023-02-09.
Discontinued › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2023-02-09
- ACTAVIA LIFE SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2021-09-30 was $561.48K.
- ACTAVIA LIFE SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2021-06-30 was -$123.59K.
- ACTAVIA LIFE SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2020-09-30 was -$2.29M.
- ACTAVIA LIFE SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2020-06-30 was -$2.71M.
- ACTAVIA LIFE SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2021 was -$332.00.
- ACTAVIA LIFE SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2020 was -$5.35M.
- ACTAVIA LIFE SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2019 was -$943.96K.
- ACTAVIA LIFE SCIENCES, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2018 was -$4.07M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2021-09-30 | $561.48K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $437.89K derived: sum of 2 quarters · filed 2023-02-09 | -$332.00 10-K · filed 2023-02-09 | |
| 2021-06-30 | -$123.59K 10-Q · filed 2021-08-16 | -$561.81K 10-Q · filed 2021-08-16 | ||
| 2020-09-30 | -$2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-15 | -$5.00M derived: sum of 2 quarters · filed 2021-08-16 | -$5.35M 10-K · filed 2021-01-15 | |
| 2020-06-30 | -$2.71M 10-Q · filed 2021-08-16 | -$3.06M 10-Q · filed 2021-08-16 | ||
| 2019-09-30 | -$943.96K 10-K · filed 2021-01-15 | |||
| 2018-09-30 | -$4.07M 10-K · filed 2020-01-13 | |||
| 2017-09-30 | -$3.03M 10-K · filed 2018-12-24 | |||
| 2017-03-31 | -$4.43M 10-K · filed 2018-12-24 | |||
| 2016-09-30 | -$2.13M 10-KT · filed 2017-11-30 | |||
| 2016-03-31 | -$578.11K 10-KT · filed 2017-11-30 | |||
| 2015-03-31 | -$1.77M 10-KT · filed 2017-11-30 |